In the News
The U.S. Food and Drug Administration is considering a pill specifically designed to treat postpartum depression, the most common medical complication that occurs after giving birth, affecting over 13% of new female parents. Zuranolone works by regulating neurotransmitters in the brain that help manage stress and anxiety. “I think this could be life-changing for many women. I feel this pill could really help a lot of mothers struggling with depression and anxiety to feel better quickly and be able to better care for themselves and their children,” Jill Purdie, M.D., a board-certified OBGYN and medical director at Pediatrix® Medical Group. Clinical trials have been promising. “In the trials, patients had significant reduction in anxiety and depressive symptoms as well as improved day-to-day function,” said Dr. Purdie.
View the full story on Healthline